B2 Industrial Factory: Confirm Sick Room and Support Facilities

When people look at a B2 industrial factory in Singapore, the conversation often starts with bays, power supply, and loading access. Those are practical, and they matter. But there is another topic that becomes urgent the moment you are planning an operation, hiring staff, or renewing a lease. You need to know whether you can include a sick room and the other support facilities your day to day work depends on, without tripping planning rules.

B2 (“Business 2”) is a zoning category designed for general and special industries. In URA’s planning guidance, “sick room” sits under allowable ancillary uses. That means it is not random, and it is not something you can assume will be accepted in every industrial layout. The confirmation has to be done properly, at the right stage, with the right documents.

This guide is written for operators and buyers who are evaluating B2 industrial space, B2 general industry factory layouts, or a new B2 general industrial unit, and want a clear path to confirm sick room and support facilities before money and time disappear into rework.

First, what “B2 industrial space” actually means for what you can build

If you ask “what is B2 industrial space,” the short answer is that it is industrial zoning in Singapore for general and special industries. In practical terms, URA expects B2 sites to allocate the bulk of their industrial development for industrial, or predominant, uses.

One of the key planning parameters is the “use quantum” requirement. B2 sites must use at least 60% of total industrial GFA for industrial or predominant uses. Up to 40% may be ancillary or support uses. That split matters because sick room is Sengkang Connection Official Site listed among allowable ancillary uses, and it competes for the ancillary share.

So when you are thinking about B2 industrial factory planning, your sick room discussion is not just about “do we have space for it.” It is also about the wider allocation of industrial GFA across predominant and ancillary components, and whether the development’s approvals align with what you want to do.

URA also sets out allowable predominant uses, and these include manufacturing (general industry), repair and servicing, production, assembly, storage of certain chemical or oil-related activities, industrial training, and other listed items. Alongside that, URA lists allowable ancillary uses. These include office, meeting room, sick room, diesel or pump point, M&E services, showroom, industrial canteen, and selected commercial uses.

This is why “B2 factories in Singapore” can look similar on the outside but behave very differently inside. One unit may sit in a development that already has a planned, approved ancillary structure. Another unit may be in a development where the ancillary allowance is tightly managed, or where the “white component” allocations are treated differently.

Sick room in B2: why it is allowable, but still needs confirmation

URA’s guidance explicitly lists “sick room” as an allowable ancillary use in B2. On paper, that is reassuring. It tells you sick room is within the permitted universe for B2 developments, so long as the rest of the planning picture is consistent.

However, allowable does not mean “any location, any size, any configuration, and any timing is automatically approved for your exact setup.” In real leasing and fit-out projects, the approval reality depends on what the development already received, how it is configured, and what changes your operator intends to make.

In my experience, the biggest failure mode is treating sick room as a standard interior fit-out item, like installing a partition and a sink, without checking whether the development’s approved layout and ancillary allocation can accommodate your plan. Sometimes the unit is leased as part of a multi-user development. Sometimes the development includes separate industrial and “white” buildings or a white component that can be strata-subdivided in certain cases, but with restrictions on land subdivision. Those nuances affect how changes are assessed.

For B2 industrial factory operators, the confirmation work should happen before you lock in your final floor plan, before you sign off on drawings, and certainly before you begin construction. If your plan changes after approval assumptions are made, the rework is expensive in both time and momentum.

The planning levers you should check: GFA mix, ancillaries, and “white component” realities

To confirm sick room and support facilities in a B2 industrial development, you need to understand what levers URA uses and how they show up in development documents.

1) The 60% predominant and 40% ancillary balance

Because B2 sites must use at least 60% of total industrial GFA for industrial or predominant uses, and up to 40% for ancillary or support uses, your sick room sits inside an allocation logic.

If your operator plan increases ancillary space, or relies on multiple ancillary facilities at the same time, you may run into constraints. This is not a “gotcha” so much as a structural rule for B2 developments.

Even if you personally only need a modest sick room, the bigger question is how the development’s ancillary portion has been committed, by previous approvals and the existing tenant mix in a multi-user building.

2) Ancillary uses are allowed, but they must be treated as ancillary

URA’s list of ancillary uses includes sick room, office, meeting room, diesel or pump point, M&E services, showroom, industrial canteen, and selected commercial uses. The practical implication is that sick room should be planned as part of the ancillary offering for the site, not as something that expands into a “predominant-like” footprint.

If your sick room plan gradually becomes something like an additional medical or training function, or it starts to look operationally independent from industrial use, you risk mismatch with how the space is categorized.

3) White component space can be a different conversation

URA notes that “white component” space in B2 developments may allow specific uses such as shop, restaurant, showroom, association and C&CI uses, office, commercial school, and sports or recreation or fitness uses. The key phrase is that these are subject to planning evaluation.

This matters because some developments have both industrial buildings and white buildings. In certain B2 cases, white components in industrial developments may be strata-subdivided, but there must be no land subdivision. If your sick room requirement is being assumed to “belong” to a white component, or if you are planning multiple support facilities that you think will fall under a white allocation, you should clarify how the development treats these spaces.

A common trap is using language like “it’s just support space” to cover everything. But URA’s framework treats predominant versus ancillary as a substantive planning distinction, and white component rules may introduce additional evaluation steps.

4) GPR minimum and unlocking GPR for white uses

URA notes that a minimum GPR of 2.0 must be achieved and used for industrial purposes before remaining GPR 0.5 may be unlocked for white uses on certain B2 sites.

This is not the kind of requirement you negotiate during an interior renovation. It is a structural site capability point. Still, if you are evaluating whether a development can support particular combinations of industrial and white uses, understanding this logic helps you avoid wishful thinking when you compare B2 industrial factories or B2 general industrial units across different sites.

What “support facilities” usually includes, and where sick room fits in

The term “support facilities” can get fuzzy quickly, especially in marketing brochures. In URA’s B2 guidance, “support” sits within the ancillary uses framework, which includes sick room. It also includes other items that can be essential to how an industrial operation runs.

For a factory operator, support facilities are rarely optional. Even if your process is highly automated, people still need meeting space, some administrative functions, basic on-site provisioning, and a place to handle minor incidents without sending everyone to an external facility immediately.

In practical terms, sick room is usually discussed together with office space and meeting rooms, because those are linked to staffing and supervision. URA lists both as allowable ancillary uses, and that often leads to a coherent plan: offices for management and coordination, meeting room for briefings, and sick room for immediate first response.

Some operations also consider industrial canteen use and certain selected commercial uses, but those should be assessed carefully within the ancillary share and any applicable white component evaluation.

B2 showrooms are not the same as a sick room plan, but the comparison teaches you what “control” looks like

It is easy to lump “showroom” into the same bucket as “sick room” because both sound like non-production rooms. But URA’s guidance indicates B2 showrooms are tightly controlled. They are mainly for display of bulky or non-over-the-counter products, or products delivered or installed off-site. They are not for on-site sale, and generally need agency endorsement.

Why bring this up in an article about sick rooms? Because it is a useful reminder: in B2, non-production spaces can have different levels of planning sensitivity.

Sick room is listed as an allowable ancillary use, which gives you a clearer baseline. Still, you should treat any plan for support facilities as something to confirm through the development’s approval context, rather than assuming you can combine any accessory activity freely.

Confirming the sick room and support facilities you need: a due diligence approach

You can confirm much of this through structured questions to the landlord, development manager, or property agent, plus a review of the relevant planning permissions and drawings for the specific unit and development.

Here is the most practical due diligence checklist I recommend when evaluating a B2 industrial factory or considering a purchase of a new B2 industrial space.

• Ask whether sick room is already provided within the approved ancillary layout for the development, and whether your specific unit can include or modify it without triggering approval issues.
• Request the approved plans or drawings that show where ancillary uses sit in the development or building, not just a marketing layout.
• Confirm how the development manages the industrial GFA split, especially the baseline that supports ancillary uses like sick room.
• Check whether your planned support facilities are intended as ancillary uses, and whether any of your proposed functions might be treated as white component uses that need evaluation.
• Clarify any restrictions on “strata-subdividing” or partition changes in multi-user B2 setups, since “approved context” often matters more than what feels physically possible.

Notice what is not on the list. I am not saying you should assume sick room is automatically “fine” just because URA allows it. Instead, you are verifying that your unit and your intended alterations sit inside what the development can lawfully support.

Fit-out stage: how to think about sick room without building a planning mismatch

Once you have confirmed that sick room is intended to be allowed in your unit or building context, you still need to design it in a way that aligns with its ancillary role.

In fit-out discussions, operators often want a sick room that can be used for more than minor first aid, especially when staffing is lean or shift patterns stretch. That pressure is understandable. But from a planning perspective, it is smarter to define the sick room scope clearly as a support facility, not as a separate medical practice space.

Trade-offs come up here. A unit with a limited footprint may push you to convert an existing corner office or part of a meeting area into a sick room. That can work, but only if the area is still treated as ancillary and the development’s ancillary allowance and approved categories remain consistent.

Another edge case is when your plan includes multiple support facilities. If you need a sick room plus offices, meeting rooms, and possibly an industrial canteen arrangement within the same internal configuration, you should confirm that the combined support footprint stays aligned with the approved approach for the development. The URA 60% predominant versus up to 40% ancillary logic is a site-level discipline, but it becomes operationally real when tenant fit-out plans start to scale beyond what was originally assumed.

B2 factories in Singapore, multi-user setups, and why “same zoning” does not mean “same answer”

People often compare B2 industrial units and say, “This one is also B2, why can’t I do the same sick room setup there?”

Because “B2 general industrial” is a zoning umbrella, but the actual unit outcome can change based on how the site was approved and how it is arranged.

Some B2 developments have separate industrial and white buildings. In such cases, the way ancillary uses are located and managed may differ. URA also notes that white components in industrial developments may allow strata-subdivision in certain cases, but without land subdivision.

If your operation is in a multi-user B2 arrangement, your sick room plan also has to consider what other users have already occupied or modified. Even if your own modifications are small, the cumulative effect on how a building allocates ancillary space can matter for confirmation.

So when you see “B2 factories in Singapore” listings, treat them as starting points, not final answers. Your due diligence conversation should be specific to the building’s approvals and the unit’s permitted configuration, not just the zoning label.

Buying versus renting: how sick room confirmation affects your decision

Some buyers are searching for “buy B2 general industry factory” opportunities or “upcoming new B2 industrial space.” Others are renting a B2 industrial space to test demand or ramp production.

The sick room and support facility confirmation affects both paths, but in different ways.

If you buy, your longer-term investment exposure makes early confirmation even more valuable. If the development’s approved ancillary configuration does not align with your needs, you are living with that mismatch for years. That is costly.

If you rent, you still need confirmation, but your plan can be more flexible. Renting can allow you to choose a unit whose layout already supports the ancillary uses you need, rather than trying to create them from scratch.

Either way, keep your focus on the same fundamental question: can the sick room and your other support facilities be accommodated within the development’s allowable uses and approved planning context?

Practical examples of what “confirmation” might look like in the real world

To make this less abstract, imagine two scenarios you might encounter when searching for B2 general industry factory space or a new B2 industrial space.

In the first scenario, the development already includes a sick room concept as part of its approved ancillary layout. The tenant handbook or leasing pack references it, and the landlord can point you to drawings that show the location and general function. In this case, your main work is to validate whether the unit you are taking can incorporate the sick room without altering approved categories or triggering additional reviews. Your fit-out becomes more of a “refinement” than a “creation.”

In the second scenario, the listing mentions “support facilities” broadly, but the unit plan you receive only shows offices and meeting areas, with no sick room clearly mapped. You still can confirm that sick room is allowable in B2, but you now need to verify whether that specific development approval framework can accommodate an added sick room in your unit. If it requires changes that affect the ancillary share, building circulation, or the way spaces are categorized, you will want to know early.

Those differences are why operators who only focus on rent and industrial clearance sometimes get burned. Sick room is not a luxury add-on, it is part of how staff safety and operations are supported.

How to talk to stakeholders so you get a clear answer fast

A lot of confusion happens because questions are too vague. “Can we have a sick room?” is not enough. You need answers tied to the unit and development context.

When I help teams prepare their questions, I suggest they speak in terms that mirror the planning concepts: ancillary uses, approved layouts, and development-level constraints like the predominant versus ancillary GFA balance. That approach makes it easier for landlords and managers to respond with meaningful documentation instead of generic reassurance.

If you want to keep it simple, your conversation can focus on three points, not ten. First, whether sick room is already contemplated or approved. Second, whether you can modify or add it within your unit. Third, whether any other support facilities you need are likely to be treated within ancillary use allowances or if they might touch white component evaluation.

That is usually enough to surface the real constraints quickly.

Where keywords and your search strategy connect (without forcing the issue)

If you are searching for “B2 industrial factory,” “B2 industrial space,” “B2 general industry factory,” or “B2 factories in Singapore,” you may see layouts marketed with different levels of detail. Some may emphasize “new b2 general industrial” attributes like modern specs and fresh interiors, while others focus on tenant convenience or shared facilities.

A smart strategy is to treat sick room and support facilities as a screening criterion, not a final detail. When you evaluate any “new B2 factory” or “upcoming new B2 industrial space,” ask the confirmation questions early, before you invest in detailed design. This reduces the risk that you later discover the development is already operating near its ancillary allocation assumptions, or that adding sick room would require a planning path you are not ready for.

Similarly, if you are considering “buy B2 general industry factory,” remember that confirmation is part of the due diligence that protects your purchase. The zoning label is a starting point, but the approvals and the approved allocation of ancillary uses is where sick room viability becomes real.

Final practical guidance: treat sick room as a planning item, not only a facility

URA’s guidance gives a clear baseline: sick room is an allowable ancillary use in B2, and B2 sites must meet a 60% industrial or predominant use requirement with up to 40% ancillary or support uses. That framework is what you should anchor your confirmation on.

From there, your success depends on execution. You need to confirm, with actual approved plans or credible documentation, how sick room and other support facilities fit into the development’s planning structure, especially in multi-user and strata-related contexts where “approved context” often matters.

If you handle it early, sick room becomes a straightforward support facility that supports safety and operations. If you postpone confirmation, it can turn into a late-stage planning constraint that disrupts your schedule and your budget.

When you next review a B2 industrial factory unit, try one shift in mindset. Don’t only ask whether you can fit a room. Ask whether the development can lawfully support that ancillary use in the way you intend to use it. That is the difference between a smooth start and a painful renovation detour.